Prostate Cancer Screening: As Effective As Breast Cancer Tests?

A landmark study indicates that offering prostate-specific antigen (PSA) blood tests to men over 45 could be as effective as the current breast cancer screening program. Researchers compared data from nearly 40,000 men who received PSA tests between ages 45 and 50 with 2.8 million women undergoing mammograms. The findings suggest both screening methods identified cancer cases with approximately 74% accuracy.

Despite these similarities, the PSA test showed a 10% higher rate of false positives compared to mammograms. This is a critical point, as the UK National Screening Committee previously rejected calls for a national prostate cancer screening program, citing accuracy concerns. Advocates argue that the benefits of early detection now outweigh the harms.

However, some medical professionals caution against direct comparisons, noting that breast cancer screening's success is also debated. They highlight that prostate cancer treatments can cause significant functional harms, unlike many breast cancer treatments. The discussion continues regarding the psychological impact of false positives and the definition of a clinically significant diagnosis.